Home > Category > Signaling Pathways > Protein Tyrosine Kinase/RTK > Bcr-Abl > Olverembatinib dimesylate (GZD824 dimesylate; HQP1351 dimesylate)

Olverembatinib dimesylate (GZD824 dimesylate; HQP1351 dimesylate)

ChemLeader 98+%

Catalog No：CL2492A CAS No.：1421783-64-3 MDLNo： Formula：C31H35F3N6O7S2 MW：724.77

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
5 mg	3-5days	$175.00	Visible after login	- +
10 mg	3-5days	$260.00	Visible after login	- +
25 mg	3-5days	$450.00	Visible after login	- +

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	Olverembatinib dimesylate (GZD824 dimesylate; HQP1351 dimesylate)
CAS	1421783-64-3
Formula	C31H35F3N6O7S2
MW	724.77
Appearance	Light yellow to yellow powder
Storage condition	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

Product details

Olverembatinib (GZD824) dimesylate is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History

CL2492A

Olverembatinib dimesylate (GZD824 dimesylate; HQP1351 dimesylate)

1421783-64-3 98+%

CLA1310

Parsatuzumab (Anti-EGFL7)

1312797-14-0 95+%